CLOTTING FACTOR
Overview
Novoeight is approved by the Food and Drug Administration (FDA) to control and prevent bleeding episodes in children and adults with hemophilia A. Novoeight can also be used for perioperative (before, during, and after surgery) care and routine prophylaxis. The technical name of Novoeight is Antihemophilic factor (recombinant).
Novoeight is a clotting factor. Clotting factors work by supplying proteins missing in people with hemophilia.
How do I take it?
Prescribing information states that Novoeight is given as an intravenous injection.
Novoeight comes as a powder that must be reconstituted before injection.
Side effects... read more
We never share your personal information with anyone.